MarketFriction

Kobo Biotech Ltd

BSE 531541 · Commodity Chemicals
₹3.62 -1.90%
BSE close2026-10-01
Market cap₹9.12 Cr.

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Sales0.000.000.000.000.000.000.000.000.000.000.000.00
Expenses0.700.309.240.340.210.170.790.230.200.200.250.34
Operating Profit-0.70-0.30-9.24-0.34-0.21-0.17-0.79-0.23-0.20-0.20-0.25-0.34
OPM %
Other Income0.000.000.000.020.000.000.000.020.000.000.000.02
Interest0.130.000.000.000.000.000.000.000.000.000.000.00
Depreciation1.031.041.181.150.891.031.001.011.021.031.011.01
Profit before tax-1.86-1.34-10.42-1.47-1.10-1.20-1.79-1.22-1.22-1.23-1.26-1.33
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit-1.86-1.35-10.42-1.47-1.10-1.19-1.79-1.23-1.22-1.23-1.26-1.33
EPS in Rs-0.78-0.57-4.37-0.62-0.46-0.50-0.75-0.52-0.51-0.52-0.53-0.56
Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Sales56.8929.0532.540.000.000.000.000.000.000.000.000.00
Expenses61.3438.5127.744.053.021.720.692.7910.511.500.881.24
Operating Profit-4.45-9.464.80-4.05-3.02-1.72-0.69-2.79-10.51-1.50-0.88-1.24
OPM %-7.82%-32.56%14.75%
Other Income0.182.600.426.000.04-2.150.030.040.020.020.020.08
Interest18.1415.6214.3714.4114.5014.4414.4710.840.130.000.000.00
Depreciation9.627.787.316.786.446.155.885.644.614.074.074.07
Profit before tax-32.03-30.26-16.46-19.24-23.92-24.46-21.01-19.23-15.23-5.55-4.93-5.23
Tax %1.69%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit-32.57-30.26-16.46-19.24-23.92-24.46-21.01-19.23-15.23-5.55-4.93-5.23
EPS in Rs-14.48-13.45-6.94-8.08-10.04-10.27-8.82-8.07-6.39-2.33-2.07-2.20
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%%%%
Compounded Profit Growth6%12%18%-6%
Stock Price CAGR-5%-1%11%64%
Return on Equity%%%%
Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital22.5022.5023.7323.8323.8323.8323.8323.8323.8323.8323.8323.83
Reserves22.07-8.83-17.30-42.41-66.33-90.79-111.80-131.03-146.25-151.81-156.74-161.97
Borrowings136.99142.42152.68207.60221.96236.36250.76260.53140.71139.84139.69139.69
Other Liabilities97.4595.74101.3663.2066.4870.0473.5477.2660.8963.4764.6270.04
Total Liabilities279.01251.83260.47252.22245.94239.44236.33230.5979.1875.3371.4071.59
Fixed Assets103.5295.1087.7981.0174.5668.4262.5456.9141.6637.5933.5229.44
CWIP2.252.252.252.252.252.252.252.250.000.000.000.00
Investments12.1912.1912.1912.1912.1912.1912.1912.190.000.000.000.00
Other Assets161.05142.29158.24156.77156.94156.58159.35159.2437.5237.7437.8842.15
Total Assets279.01251.83260.47252.22245.94239.44236.33230.5979.1875.3371.4071.59
Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity11.0219.325.6232.3031.4720.9514.482.5193.760.870.204.18
Cash from Investing Activity-4.710.000.000.000.000.000.000.0025.090.000.000.00
Cash from Financing Activity-7.00-20.50-5.27-32.76-31.47-20.95-14.47-1.08-120.28-0.87-0.150.00
Net Cash Flow-0.69-1.180.35-0.460.000.000.001.43-1.430.000.054.18
Free Cash Flow6.3119.325.6232.3031.4720.9514.482.51106.650.870.204.18
CFO/OP-260%-204%117%-798%-1,042%-1,218%-2,099%-90%-892%-58%-23%-337%
Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days419.02705.621,006.50
Inventory Days585.06896.421,038.63
Days Payable404.72659.541,092.57
Cash Conversion Cycle599.37942.51952.56
Working Capital Days26.63-276.67-251.48
ROCE %-7.12%-10.18%-1.33%-2.77%-5.11%-4.49%-3.94%-5.31%-17.60%-36.82%-52.90%-125.57%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters44.95%44.95%44.95%44.95%44.95%44.95%44.95%44.95%44.95%44.95%44.95%44.95%
DIIs0.66%0.66%0.66%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Public54.39%54.37%54.39%55.06%55.05%55.05%55.04%55.05%55.05%55.05%55.05%55.05%
No. of Shareholders6,4786,5306,7676,7886,9167,5427,8737,9297,9477,9707,9777,734

Fundamentals

Market Cap₹ 9.12 Cr.
Current Price₹ 3.83
Book Value₹ -58.0
ROCE-126 %
ROE%
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)%
Compounded Profit Growth (TTM)-6%
Standalone figures.
Valuation
Market capRs 9 Cr
Enterprise valueRs 144 Cr
Price to book-0.06x
Price to cash flow2.06x
Earnings yield-58.44%
P/B, 3-year average-0.05x
P/B, 5-year average-0.09x
Profitability
ROE3.86%
ROCE-125.57%
ROA-7.32%
ROE, 3-year average4.02%
ROCE, 3-year average-71.76%
ROA, 3-year average-7.07%
ROE, 5-year average9.01%
ROCE, 5-year average-47.64%
ROA, 5-year average-7.86%
Other income / net worth-0.06%
Per share
EPS (TTM)Rs -2.12
EPS (latest year)Rs -2.20
EPS (latest quarter)Rs -0.56
EPS, 3-year averageRs -2.20
EPS, 5-year averageRs -4.21
Book value per shareRs -57.98
Cash flow per shareRs 1.75
Free cash flow per shareRs 1.75
Efficiency
Inventory turnover0.00x
Inventory days109743 days
Creditor days1093 days
Cash conversion cycle953 days
Working capital days-251 days
Leverage
Total debtRs 140 Cr
Cash and bankRs 4 Cr
Net debtRs 135 Cr
Debt to equity-1.01x
Owners' fund to total sources-192.96%
Debt to assets195.12%
Cash flow
Cash from Operating Activity (latest year)Rs 4 Cr
Net Cash Flow (latest year)Rs 4 Cr
Free cash flow (latest year)Rs 4 Cr
FCFE (approx.: FCF + change in debt)Rs 4 Cr
Statement figures
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs -1 Cr
PBDT (TTM)Rs -1 Cr
Profit before tax (TTM)Rs -5 Cr
Net profit (TTM)Rs -5 Cr
Net profit (latest year)Rs -5 Cr
Net profit (latest quarter)Rs -1 Cr
Depreciation (TTM)Rs 4 Cr
Depreciation (latest quarter)Rs 1 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total income (latest year)Rs 0 Cr
Share capitalRs 24 Cr
ReservesRs -162 Cr
Shareholders' fundsRs -138 Cr
Total assetsRs 72 Cr
Net blockRs 29 Cr
ReceivablesRs 12 Cr
InventoryRs 18 Cr
Other liabilitiesRs 70 Cr
Shares outstanding (crore)2.38
Ownership
Promoter holding44.95% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Period531541Nifty 50Difference
1 week-8.8%-2.8% -6.0 pts
1 month-36.7%-6.8% -29.9 pts
3 months-53.7%-7.6% -46.1 pts
3 years+30.2%+14.2% +16.0 pts
5 years-11.7%+27.9% -39.6 pts

Red flags

F-score 4 of 6
seriousNegative equity Shareholders' equity is negative
lookRepeated losses Net loss in each of the last two years
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2024
Sales ₹0 Cr. Net loss ₹1 Cr.

Activity

Compare
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Kobo Biotech Ltd?

Kobo Biotech Ltd (531541) has a market capitalisation of Rs 9.12 Cr. at the 2026-10-01 close.

What were Kobo Biotech Ltd's latest quarterly results?

In the Jun 2024 quarter, Kobo Biotech Ltd sales was Rs 0 Cr with a net loss of Rs 1 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03